2021 Q1 Form 10-Q Financial Statement
#000156459021031793 Filed on June 04, 2021
Income Statement
Concept | 2021 Q1 |
---|---|
Revenue | $480.0K |
YoY Change | |
Cost Of Revenue | |
YoY Change | |
Gross Profit | |
YoY Change | |
Gross Profit Margin | |
Selling, General & Admin | $597.0K |
YoY Change | |
% of Gross Profit | |
Research & Development | $3.106M |
YoY Change | |
% of Gross Profit | |
Depreciation & Amortization | $544.0K |
YoY Change | |
% of Gross Profit | |
Operating Expenses | $4.773M |
YoY Change | |
Operating Profit | -$4.293M |
YoY Change | |
Interest Expense | $222.0K |
YoY Change | |
% of Operating Profit | |
Other Income/Expense, Net | -$2.901M |
YoY Change | |
Pretax Income | -$7.194M |
YoY Change | |
Income Tax | -$53.00K |
% Of Pretax Income | |
Net Earnings | -$7.141M |
YoY Change | |
Net Earnings / Revenue | -1487.71% |
Basic Earnings Per Share | -$0.10 |
Diluted Earnings Per Share | -$0.10 |
COMMON SHARES | |
Basic Shares Outstanding | 70.09M |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q1 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | |
YoY Change | |
Cash & Equivalents | $6.780M |
Short-Term Investments | |
Other Short-Term Assets | |
YoY Change | |
Inventory | |
Prepaid Expenses | |
Receivables | |
Other Receivables | |
Total Short-Term Assets | $3.538M |
YoY Change | |
LONG-TERM ASSETS | |
Property, Plant & Equipment | |
YoY Change | |
Goodwill | |
YoY Change | |
Intangibles | |
YoY Change | |
Long-Term Investments | |
YoY Change | |
Other Assets | |
YoY Change | |
Total Long-Term Assets | $350.6M |
YoY Change | |
TOTAL ASSETS | |
Total Short-Term Assets | $3.538M |
Total Long-Term Assets | $350.6M |
Total Assets | $354.1M |
YoY Change | |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | $1.317M |
YoY Change | |
Accrued Expenses | $480.2K |
YoY Change | |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | |
YoY Change | |
Long-Term Debt Due | |
YoY Change | |
Total Short-Term Liabilities | $1.958M |
YoY Change | |
LONG-TERM LIABILITIES | |
Long-Term Debt | |
YoY Change | |
Other Long-Term Liabilities | |
YoY Change | |
Total Long-Term Liabilities | |
YoY Change | |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $1.958M |
Total Long-Term Liabilities | |
Total Liabilities | $40.09M |
YoY Change | |
SHAREHOLDERS EQUITY | |
Retained Earnings | -$36.99M |
YoY Change | |
Common Stock | $6.166M |
YoY Change | |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | |
YoY Change | |
Treasury Stock Shares | |
Shareholders Equity | $1.693M |
YoY Change | |
Total Liabilities & Shareholders Equity | $354.1M |
YoY Change |
Cashflow Statement
Concept | 2021 Q1 |
---|---|
OPERATING ACTIVITIES | |
Net Income | -$7.141M |
YoY Change | |
Depreciation, Depletion And Amortization | $544.0K |
YoY Change | |
Cash From Operating Activities | -$3.643M |
YoY Change | |
INVESTING ACTIVITIES | |
Capital Expenditures | $68.00K |
YoY Change | |
Acquisitions | |
YoY Change | |
Other Investing Activities | |
YoY Change | |
Cash From Investing Activities | -$97.00K |
YoY Change | |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | $25.00K |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | 5.546M |
YoY Change | |
NET CHANGE | |
Cash From Operating Activities | -3.643M |
Cash From Investing Activities | -97.00K |
Cash From Financing Activities | 5.546M |
Net Change In Cash | 1.806M |
YoY Change | |
FREE CASH FLOW | |
Cash From Operating Activities | -$3.643M |
Capital Expenditures | $68.00K |
Free Cash Flow | -$3.711M |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2021Q1 | dei |
Entity File Number
EntityFileNumber
|
001-40284 | |
CY2021Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2021Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Decarbonization Plus Acquisition Corporation III | |
CY2021Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2021Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Menlo Park | |
CY2021Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001844862 | |
CY2021Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2021Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2021Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
86-1888095 | |
CY2021Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2021Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | |
CY2021Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2021Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
94025 | |
CY2021Q1 | dei |
City Area Code
CityAreaCode
|
212 | |
CY2021Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
993-0076 | |
CY2021Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | |
CY2021Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2744 Sand Hill Road | |
CY2021Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 100 | |
CY2021Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2021Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-03-31 | |
CY2021Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2021Q1 | dcrc |
Common Stock Threshold Trading Period
CommonStockThresholdTradingPeriod
|
P20D | |
CY2021Q1 | dcrc |
Common Stock Consecutive Trading Period
CommonStockConsecutiveTradingPeriod
|
P30D | |
CY2021Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2021Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2021Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2021Q1 | us-gaap |
Cash
Cash
|
2986880 | |
CY2021Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
551380 | |
CY2021Q1 | us-gaap |
Assets Current
AssetsCurrent
|
3538261 | |
CY2021Q1 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
350000172 | |
CY2021Q1 | dcrc |
Prepaid Insurance Non Current
PrepaidInsuranceNonCurrent
|
560596 | |
CY2021Q1 | us-gaap |
Assets
Assets
|
354099028 | |
CY2021Q1 | dcrc |
Accounts Payable Offering Costs Affiliate
AccountsPayableOfferingCostsAffiliate
|
160538 | |
CY2021Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1317442 | |
CY2021Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
480200 | |
CY2021Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1958180 | |
CY2021Q1 | dcrc |
Warrant Liabilities
WarrantLiabilities
|
26883334 | |
CY2021Q1 | dcrc |
Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
|
12250000 | |
CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
41091514 | |
CY2021Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
308007510 | |
CY2021Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
6043810 | |
CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1045232 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5000004 | |
CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
354099028 | |
CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
205486 | |
CY2021Q1 | dcrc |
Offering Costs Allocated To Warrant Liabilities
OfferingCostsAllocatedToWarrantLiabilities
|
956584 | |
CY2021Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-116666 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1045232 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2868852 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.00 | |
CY2021Q1 | dcrc |
Weighted Average Shares Outstanding Of Nonredeemable Common Stock Basic And Diluted
WeightedAverageSharesOutstandingOfNonredeemableCommonStockBasicAndDiluted
|
9072746 | |
CY2021Q1 | dcrc |
Basic And Diluted Net Income Loss Per Common Share Nonredeemable Common Stock
BasicAndDilutedNetIncomeLossPerCommonShareNonredeemableCommonStock
|
-0.12 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
25000 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
313750000 | |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
678838 | |
CY2021Q1 | dcrc |
Adjustments To Additional Paid In Capital Cash Paid In Excess Of Fair Value Of Private Placement Warrants
AdjustmentsToAdditionalPaidInCapitalCashPaidInExcessOfFairValueOfPrivatePlacementWarrants
|
956584 | |
CY2021Q1 | dcrc |
Stock Issued During Period Value Subject To Redemption
StockIssuedDuringPeriodValueSubjectToRedemption
|
308007510 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1045232 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5000004 | |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-1045232 | |
CY2021Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-116666 | |
CY2021Q1 | dcrc |
Offering Costs Allocated To Warrant Liabilities
OfferingCostsAllocatedToWarrantLiabilities
|
956584 | |
CY2021Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2021Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2021Q1 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-205486 | |
CY2021Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
172 | |
CY2021Q1 | dcrc |
Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
|
172 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
1317442 | |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
|
1111977 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-20 | |
CY2021Q1 | dcrc |
Investment Of Cash In Trust Account
InvestmentOfCashInTrustAccount
|
350000000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-350000000 | |
CY2021Q1 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
343000000 | |
CY2021Q1 | dcrc |
Proceeds From Sale Of Private Placement Warrants
ProceedsFromSaleOfPrivatePlacementWarrants
|
10000000 | |
CY2021Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
25000 | |
CY2021Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
38100 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
352986900 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
2986880 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2986880 | |
CY2021Q1 | dcrc |
Initial Classification Of Class A Common Stock To Possible Redemption
InitialClassificationOfClassACommonStockToPossibleRedemption
|
307889890 | |
CY2021Q1 | dcrc |
Change In Initial Value Of Class A Common Stock To Possible Redemption
ChangeInInitialValueOfClassACommonStockToPossibleRedemption
|
117620 | |
CY2021Q1 | dcrc |
Accrued Offering Costs
AccruedOfferingCosts
|
640738 | |
CY2021Q1 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2021-01-29 | |
CY2021Q1 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
19928838 | |
CY2021Q1 | dcrc |
Underwriting Fees
UnderwritingFees
|
7000000 | |
CY2021Q1 | dcrc |
Deferred Underwriting Fees
DeferredUnderwritingFees
|
12250000 | |
CY2021Q1 | dcrc |
Other Offering Costs
OtherOfferingCosts
|
678838 | |
CY2021Q1 | us-gaap |
Cash
Cash
|
2986880 | |
CY2021Q1 | dcrc |
Proceeds From Stock Offering Held In Trust Account
ProceedsFromStockOfferingHeldInTrustAccount
|
350000000 | |
CY2021Q1 | dcrc |
Redemption Percentage Of Public Shares If Business Combination Not Completed
RedemptionPercentageOfPublicSharesIfBusinessCombinationNotCompleted
|
1 | |
CY2021Q1 | dcrc |
Redemption Percentage Of Public Shares If Business Combination Not Completed
RedemptionPercentageOfPublicSharesIfBusinessCombinationNotCompleted
|
1 | |
CY2021Q1 | dcrc |
Threshold Period For Redemption Of Public Shares
ThresholdPeriodForRedemptionOfPublicShares
|
P24M | |
CY2021Q1 | dcrc |
Net Tangible Assets Threshold Limit For Redemption Of Public Shares
NetTangibleAssetsThresholdLimitForRedemptionOfPublicShares
|
5000001 | |
CY2021Q1 | dcrc |
Warrant Liabilities
WarrantLiabilities
|
27000000 | |
CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
40086989 | |
CY2021Q1 | dcrc |
Temporary Equity Subject To Possible Redemption
TemporaryEquitySubjectToPossibleRedemption
|
307899890 | |
CY2021Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
6165789 | |
CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1167215 | |
CY2021Q1 | dcrc |
Warrants Exercise Period Following Business Combination
WarrantsExercisePeriodFollowingBusinessCombination
|
P30D | |
CY2021Q1 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
CY2021Q1 | dcrc |
Number Of Fractional Warrants Be Issued
NumberOfFractionalWarrantsBeIssued
|
0 | |
CY2021Q1 | dcrc |
Period For Completion Of Business Combination From Closing Of Initial Public Offering
PeriodForCompletionOfBusinessCombinationFromClosingOfInitialPublicOffering
|
P24M | |
CY2021Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
172 | |
CY2021Q1 | dcrc |
Redeemable Common Stock Net Income Loss
RedeemableCommonStockNetIncomeLoss
|
172 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.00 | |
CY2021Q1 | dcrc |
Redeemable Common Stock Net
RedeemableCommonStockNet
|
-172 | |
CY2021Q1 | dcrc |
Basic And Diluted Net Income Loss Per Common Share Nonredeemable Common Stock
BasicAndDilutedNetIncomeLossPerCommonShareNonredeemableCommonStock
|
-0.12 | |
CY2021Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.13%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.13%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limits of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p> | |
CY2021Q1 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
250000 | |
CY2021Q1 | us-gaap |
Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
|
5250000 | |
CY2021Q1 | dcrc |
Monthly Fees Payable Outstanding To Affiliate Of Sponsor
MonthlyFeesPayableOutstandingToAffiliateOfSponsor
|
1935 | |
CY2021Q1 | dcrc |
Amount Borrowed Under Working Capital Loan
AmountBorrowedUnderWorkingCapitalLoan
|
0 | |
CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.13%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.13%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statement in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of this financial statement. Actual results could differ from those estimates.</p> | |
CY2021Q1 | us-gaap |
Cash
Cash
|
2986880 | |
CY2021Q1 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
350000172 | |
CY2021Q1 | us-gaap |
General Partners Offering Costs
GeneralPartnersOfferingCosts
|
18972254 | |
CY2021Q1 | dcrc |
Expensed Offering Costs
ExpensedOfferingCosts
|
956584 | |
CY2021Q1 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
0 | |
CY2021Q1 | dcrc |
Underwriters Option Period To Purchase Shares
UnderwritersOptionPeriodToPurchaseShares
|
P45D | |
CY2021Q1 | dcrc |
Maximum Number Of Shares Granted For Underwriters To Purchase
MaximumNumberOfSharesGrantedForUnderwritersToPurchase
|
5250000 | |
CY2021Q1 | dcrc |
Underwriting Agreement Deferred Fee Per Unit
UnderwritingAgreementDeferredFeePerUnit
|
0.35 | |
CY2021Q1 | dcrc |
Underwriting Agreement Deferred Fee Payable Upon Completion Of Business Combination
UnderwritingAgreementDeferredFeePayableUponCompletionOfBusinessCombination
|
12250000 | |
CY2021Q1 | dcrc |
Founder Shares Percentage
FounderSharesPercentage
|
0.20 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2021Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q1 | us-gaap |
Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
|
The Company’s initial stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the Initial Business Combination or (B) subsequent to the Initial Business Combination, (x) if the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. | |
CY2021Q1 | dcrc |
Minimum Holding Period For Shares After Business Combination
MinimumHoldingPeriodForSharesAfterBusinessCombination
|
P150D | |
CY2021Q1 | us-gaap |
Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
|
10000 | |
CY2021Q1 | us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
1935 | |
CY2021Q1 | dcrc |
Class Of Warrant Or Right Exercise Price Percentage
ClassOfWarrantOrRightExercisePricePercentage
|
1.15 | |
CY2021Q1 | dcrc |
Warrants Exercise Period Following Business Combination
WarrantsExercisePeriodFollowingBusinessCombination
|
P30D | |
CY2021Q1 | dcrc |
Warrants Exercise Period Following Initial Public Offering
WarrantsExercisePeriodFollowingInitialPublicOffering
|
P12M | |
CY2021Q1 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
CY2021Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-116666 | |
CY2021Q1 | us-gaap |
Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
|
0 | |
CY2021Q1 | us-gaap |
Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
|
0 | |
CY2021Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | |
CY2021Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 |